ATE42410T1 - Verfahren zur stabilisierung von, auf einem unloeslichen traeger, immobilisierten substanzen mit immunologischer wirksamkeit und ihre verwendung in der herstellung von reagenzien zur messung von substanzen mit physiologischer wirksamkeit. - Google Patents

Verfahren zur stabilisierung von, auf einem unloeslichen traeger, immobilisierten substanzen mit immunologischer wirksamkeit und ihre verwendung in der herstellung von reagenzien zur messung von substanzen mit physiologischer wirksamkeit.

Info

Publication number
ATE42410T1
ATE42410T1 AT84305286T AT84305286T ATE42410T1 AT E42410 T1 ATE42410 T1 AT E42410T1 AT 84305286 T AT84305286 T AT 84305286T AT 84305286 T AT84305286 T AT 84305286T AT E42410 T1 ATE42410 T1 AT E42410T1
Authority
AT
Austria
Prior art keywords
substances
stabilization
reagents
preparation
immobilized
Prior art date
Application number
AT84305286T
Other languages
German (de)
English (en)
Inventor
Yoshitsugu Sakata
Yoshitaka Hamaguchi
Motoo Goto
Shinzo Kobatake
Original Assignee
Wako Pure Chem Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15356567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE42410(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wako Pure Chem Ind Ltd filed Critical Wako Pure Chem Ind Ltd
Application granted granted Critical
Publication of ATE42410T1 publication Critical patent/ATE42410T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT84305286T 1983-08-05 1984-08-03 Verfahren zur stabilisierung von, auf einem unloeslichen traeger, immobilisierten substanzen mit immunologischer wirksamkeit und ihre verwendung in der herstellung von reagenzien zur messung von substanzen mit physiologischer wirksamkeit. ATE42410T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58144201A JPS6035263A (ja) 1983-08-05 1983-08-05 不溶性担体に固定化された免疫活性物質の安定化法及び該物質を構成単位として含む生理活性物質測定用試薬
EP84305286A EP0140489B1 (en) 1983-08-05 1984-08-03 Method for stabilizing immunologically active substances immobilized on an insoluble carrier and their use in the preparation of reagents for measuring physiologically active substances

Publications (1)

Publication Number Publication Date
ATE42410T1 true ATE42410T1 (de) 1989-05-15

Family

ID=15356567

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84305286T ATE42410T1 (de) 1983-08-05 1984-08-03 Verfahren zur stabilisierung von, auf einem unloeslichen traeger, immobilisierten substanzen mit immunologischer wirksamkeit und ihre verwendung in der herstellung von reagenzien zur messung von substanzen mit physiologischer wirksamkeit.

Country Status (4)

Country Link
EP (1) EP0140489B1 (en, 2012)
JP (1) JPS6035263A (en, 2012)
AT (1) ATE42410T1 (en, 2012)
DE (1) DE3477844D1 (en, 2012)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2187191B (en) * 1984-01-30 1989-11-01 Quadrant Bioresources Ltd Protection of proteins and the like
GB8500698D0 (en) * 1985-01-11 1985-02-13 Unilever Plc Preparation of reagents
JPS61241665A (ja) * 1985-04-18 1986-10-27 Toyobo Co Ltd 安定化された固相試薬
DE229810T1 (de) * 1985-07-09 1987-11-05 Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire Beschuetzung von proteinen und aehnlichem.
JPS6234059A (ja) * 1985-08-07 1987-02-14 Sankyo Co Ltd 固相化試薬の安定化剤
JPS62170850A (ja) * 1986-01-23 1987-07-27 Wako Pure Chem Ind Ltd 免疫化学的測定法
US5514602A (en) * 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
EP1248112A3 (en) 1987-04-27 2004-08-25 Inverness Medical Switzerland GmbH Immunochromatographic specific binding assay device
FR2616915B1 (fr) * 1987-06-16 1989-09-29 Ire Medgenix Sa Solution d'une substance de nature polypeptidique, et utilisation pour des dosages immunologiques
GB8716826D0 (en) * 1987-07-16 1987-08-19 Tills D Protection of proteinaceous reagents
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
US5262296A (en) * 1988-03-30 1993-11-16 Toray Industries, Inc. Freeze-dried composition containing enzyme-labeled anti-human interferon-β antibody and enzyme immunoassay kit containing the composition
DE3811659C1 (en, 2012) * 1988-04-07 1989-11-16 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De
US5077198A (en) * 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies
US5759774A (en) * 1988-05-18 1998-06-02 Cobe Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
US5192663A (en) * 1988-11-04 1993-03-09 Immucor, Inc. Article having an organic dye and a monolayer of dried mammalian cells and a method for utilizing the article
AU609332B2 (en) * 1988-11-09 1991-04-26 Biotrack, Inc. Method and composition of stabilizing and solubilizing latex reagents
US5102788A (en) * 1988-11-21 1992-04-07 Hygeia Sciences, Inc. Immunoassay including lyophilized reactant mixture
JPH02161357A (ja) * 1988-12-15 1990-06-21 Tosoh Corp 免疫測定用材料の安定化方法
FR2645967B1 (fr) * 1989-04-12 1994-04-01 Diagnostica Stago Procede d'adsorption d'un materiel immunologique, utilisation dans le domaine des reactions antigene/anticorps
USRE38385E1 (en) 1989-02-16 2004-01-13 Nektar Therapeutics Storage of materials
GB8903593D0 (en) 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
DE3919393A1 (de) * 1989-06-14 1990-12-20 Hoechst Ag Verfahren zur stabilisierung von auf festphasen immobilisierten biologisch aktiven substanzen
US6143508A (en) * 1989-06-29 2000-11-07 Rhone-Poulenc Rorer Pharmaceuticals Inc. Device and process for cell capture and recovery
CA1340565C (en) 1989-06-29 1999-05-25 Thomas B. Okarma Device and process for cell capture and recovery
AU633981B2 (en) * 1989-10-12 1993-02-11 Takeda Chemical Industries Ltd. Antigen-sensitized bead and use thereof
US5252496A (en) * 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
CA2053299A1 (en) * 1990-02-28 1991-08-29 Marvin A. Motsenbocker Immunoassay
JPH0565233A (ja) * 1991-03-08 1993-03-19 Mitsui Toatsu Chem Inc モノクローナル抗体含有凍結乾燥製剤
AU659645B2 (en) 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
ES2147185T3 (es) * 1991-10-11 2000-09-01 Abbott Lab Composicion de reactivo en dosis unitaria para ensayos por union especifica.
JP3167415B2 (ja) * 1992-04-30 2001-05-21 オリンパス光学工業株式会社 固相免疫検査における抗原細胞の保存方法
GB9211176D0 (en) * 1992-05-27 1992-07-08 Central Blood Lab Authority Assay
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
CZ286632B6 (cs) 1992-09-29 2000-05-17 Inhale Therapeutic Systems Farmaceutický prostředek
AU689217B2 (en) 1994-03-07 1998-03-26 Novartis Ag Methods and compositions for pulmonary delivery of insulin
BE1008221A3 (fr) * 1994-03-28 1996-02-20 Anda Biolog Sa Support solide fixant au moins un composant a activite biologique comprenant un site reactionnel, stabilise et procede pour son obtention.
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6309671B1 (en) 1995-04-14 2001-10-30 Inhale Therapeutic Systems Stable glassy state powder formulations
US6979576B1 (en) 1997-07-25 2005-12-27 Shu-Ching Cheng Methods of use of one step immunochromatographic device for Streptococcus A antigen
AU7590198A (en) * 1997-06-10 1998-12-30 Medlyte Diagnostics, Inc. Methods for early detection of heart disease
IL121116A (en) * 1997-06-19 2000-12-06 Savyon Diagnostics Ltd Stabilization of polypeptides for use in immunoassay procedures
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
FR2777355B1 (fr) * 1998-04-10 2000-05-12 Bio Merieux Procede de fixation d'une molecule biologique sur la surface d'un support constitue de silice ou d'oxyde metallique
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
ES2180416B1 (es) 2001-03-12 2004-06-01 BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
SI1458360T1 (sl) 2001-12-19 2011-08-31 Novartis Ag Pulmonalno dajanje aminoglikozidov
US6927062B2 (en) 2002-11-25 2005-08-09 Agdia, Inc. Controls and standards for assays and method for manufacture thereof
US20080050737A1 (en) * 2006-05-23 2008-02-28 Boaz Arieli Ambient Temperature Stable Kits for Molecular Diagnostics
JP5349838B2 (ja) 2007-11-30 2013-11-20 和光純薬工業株式会社 ｓｍａｌｌＲＮＡの取得用担体、取得方法及び取得用試薬
JP2010014685A (ja) * 2008-07-04 2010-01-21 Bio Matrix Research Inc タンパク質安定化溶液
JP5832723B2 (ja) * 2009-03-06 2015-12-16 協和メデックス株式会社 可溶性インターロイキン−２受容体定量用標準品
EP2230515B1 (en) 2009-03-16 2014-12-17 Agilent Technologies, Inc. Passivation of surfaces after ligand coupling
KR102582192B1 (ko) 2014-12-05 2023-09-25 후지필름 가부시키가이샤 Tim 단백질 결합 담체, 당해 담체를 사용한 세포외막소포 및 바이러스의 취득 방법, 제거 방법, 검출 방법 그리고 당해 담체를 포함하는 키트
JP6449221B2 (ja) * 2016-03-24 2019-01-09 三洋化成工業株式会社 粒子組成物、免疫測定用試薬及び免疫測定方法
WO2018194134A1 (ja) * 2017-04-20 2018-10-25 株式会社シノテスト 抗ペリオスチン抗体固定化担体、ペリオスチン測定試薬、及び抗ペリオスチン抗体固定化担体における抗体の安定化方法
JP7269906B2 (ja) * 2019-10-29 2023-05-09 三洋化成工業株式会社 免疫測定用試薬、免疫測定用キット及び免疫測定方法
JP7461382B2 (ja) 2020-01-15 2024-04-03 富士フイルム株式会社 抗炎症剤、及び抗炎症作用を有する細胞外小胞の製造方法
JP7425092B2 (ja) 2020-01-15 2024-01-30 富士フイルム株式会社 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法
JP7538150B2 (ja) 2020-01-15 2024-08-21 富士フイルム株式会社 血管新生剤、及び血管新生作用を有する細胞外小胞の製造方法
KR20250110928A (ko) 2022-12-28 2025-07-21 후지필름 가부시키가이샤 다공질 담체, 세포 외 소포를 취득하는 방법, 세포 외 소포를 제조하는 방법, 및, 키트
WO2025012398A1 (en) 2023-07-11 2025-01-16 Olink Proteomics Ab Dried reagents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4921052A (en, 2012) * 1972-06-16 1974-02-25
JPS5423118A (en) * 1977-07-25 1979-02-21 Kitasato Inst Vaccine for bibrio disease of bred fish
GB2016687B (en) * 1978-03-20 1982-09-08 Abbott Lab Sugar coated reagents for solid phase immunoassay
JPH0235944B2 (en, 2012) * 1980-06-20 1990-08-14 Unilever Nv
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column
AR231590A1 (es) * 1981-04-29 1984-12-28 Ciba Geigy Ag Dispositivo de analisis inmunologico y procedimiento para obtenerlo
JPS57182168A (en) * 1981-05-02 1982-11-09 Mitsubishi Chem Ind Ltd Immunochemical reagent
GB2124231B (en) * 1982-05-24 1985-10-02 Corning Glass Works Solid phase reagent for immunoassay

Also Published As

Publication number Publication date
JPS6035263A (ja) 1985-02-23
EP0140489A1 (en) 1985-05-08
JPH0541946B2 (en, 2012) 1993-06-25
EP0140489B1 (en) 1989-04-19
DE3477844D1 (en) 1989-05-24

Similar Documents

Publication Publication Date Title
ATE42410T1 (de) Verfahren zur stabilisierung von, auf einem unloeslichen traeger, immobilisierten substanzen mit immunologischer wirksamkeit und ihre verwendung in der herstellung von reagenzien zur messung von substanzen mit physiologischer wirksamkeit.
ATE16820T1 (de) Testelement zur bestimmung von glukose in hoher konzentration.
DE3889733D1 (de) Vorrichtung zur messung der konzentration und sauerstoffsättigung von hämoglobin.
DE3751537D1 (de) Polypeptid- und Proteinderivate und Verfahren zu deren Herstellung.
DE69022786D1 (de) Verfahren zur Bestimmung der Konzentration von Glucose.
FI883868A7 (fi) Anturi biologista, biokemiallista ja kemiallista koestusta varten
DE3586619D1 (de) Haematologische zusammensetzungen als referenz fuer drei populationen von leukocyten, verfahren zu deren herstellung und deren verwendung in ganzbluttestverfahren.
DE69015999D1 (de) Reagenz zur Messung von Leukozyten und Hämoglobin im Blut.
ATE76508T1 (de) Vorrichtung zur feststellung von okkultem blut.
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
DE3484383D1 (de) Vorrichtung zur messung der sauerstoffkonzentration und verfahren zu ihrer herstellung.
ATA872676A (de) Verfahren zur immobilisierung biologisch aktiver proteine
DE69026024D1 (de) Künstlicher Träger zur Immobilisierung von biologischen Proteinen und Verfahren zu seiner Herstellung
DE3851069D1 (de) Alpha-Fluoroacrylssäuresalzpolymer und seine Verwendung.
DE3669077D1 (de) Methode zur messung der menge eines immunantikoerpers im serum.
NO171282C (no) Fremgangsmaate for bestemmelse av mikrobekonsentrasjoner med en smelteagarmetode, samt deri anvendte skaaler
DE3776525D1 (de) Immunochemisches verfahren zur bestimmung von stabilem glykosiliertem haemoglobin.
DE3875825D1 (de) Verfahren zur bestimmung der absorption von thyroxin.
DE3889479D1 (de) Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung.
DE58904672D1 (de) Verfahren zur herstellung einer festphasenmatrix.
DE3781268D1 (de) Verwendung von wachstumshormonen zur stickstoffzurueckhaltung bei hypokalorischen bedingungen.
DK433787A (da) 1-phenylquinazolin-1h,3h-2,4-dioner og 1-phenylpyrido oe2,3-daapyrimidin-1h,3h-dioner, estere og syreadditionssalte deraf samt farmaceutiske midler indeholdende saadanne forbindelser
DE3685197D1 (de) Substrat fuer plasmakallikrein und methode zur messung von diese benutzenden biologischen komponenten.
ATE78604T1 (de) Verwendung von polyvinylpyrrolidon (pvp) zur truebungsminderung von seren, seren enthaltend pvp und verfahren zu deren herstellung.
DE3869860D1 (de) Verfahren zur racemisierung von optisch aktiver chrysanthemumsaeure oder deren derivaten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked